Metformin for insulin resistance in PCOS

Type: drug

Status: FDA Approved (off-label for PCOS)

Developer: Bristol-Myers Squibb (original developer)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026